Clinical Trials Browser

Phase 2 × Carcinoma, Basal Cell × Bevacizumab × Clear all

NCT00959647 2015-01-07

A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

Phase 2 Completed

19 enrolled 7 charts

DermatologicGastrointestinalGynecologic

Carcinoma, Basal Cell, Ovarian Neoplasms, Colorectal Neoplasms